Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients.

Trial Profile

Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Feb 2013

At a glance

  • Drugs Valproic acid (Primary) ; Quetiapine
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 02 Feb 2013 NCT reports actual initiation date as Jul 2005 and actual patient number as 17.
    • 25 Jan 2013 Actual end date Jun 2006 added as reported by ClinicalTrials.gov.
    • 01 Oct 2009 Results were published in Acta Psychiatrica Scandinavica.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top